180 related articles for article (PubMed ID: 31014014)
1. C-X-C Motif Chemokine Ligand 14 is a Unique Multifunctional Regulator of Tumor Progression.
Yang XY; Ozawa S; Kato Y; Maehata Y; Izukuri K; Ikoma T; Kanamori K; Akasaka T; Suzuki K; Iwabuchi H; Kurata SI; Katoh I; Sakurai T; Kiyono T; Hata RI
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31014014
[TBL] [Abstract][Full Text] [Related]
2. Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice.
Hata R; Izukuri K; Kato Y; Sasaki S; Mukaida N; Maehata Y; Miyamoto C; Akasaka T; Yang X; Nagashima Y; Takeda K; Kiyono T; Taniguchi M
Sci Rep; 2015 Mar; 5():9083. PubMed ID: 25765541
[TBL] [Abstract][Full Text] [Related]
3. Chemokine CXCL14/BRAK transgenic mice suppress growth of carcinoma cell transplants. [corrected].
Izukuri K; Suzuki K; Yajima N; Ozawa S; Ito S; Kubota E; Hata R
Transgenic Res; 2010 Dec; 19(6):1109-17. PubMed ID: 20333465
[TBL] [Abstract][Full Text] [Related]
4. Expression of tumour-suppressing chemokine BRAK/CXCL14 reduces cell migration rate of HSC-3 tongue carcinoma cells and stimulates attachment to collagen and formation of elongated focal adhesions in vitro.
Sato K; Ozawa S; Izukuri K; Kato Y; Hata R
Cell Biol Int; 2010 Apr; 34(5):513-22. PubMed ID: 20067447
[TBL] [Abstract][Full Text] [Related]
5. CXCL14 displays antimicrobial activity against respiratory tract bacteria and contributes to clearance of Streptococcus pneumoniae pulmonary infection.
Dai C; Basilico P; Cremona TP; Collins P; Moser B; Benarafa C; Wolf M
J Immunol; 2015 Jun; 194(12):5980-9. PubMed ID: 25964486
[TBL] [Abstract][Full Text] [Related]
6. Chemokine CXCL14; a double-edged sword in cancer development.
Gowhari Shabgah A; Haleem Al-Qaim Z; Markov A; Valerievich Yumashev A; Ezzatifar F; Ahmadi M; Mohammad Gheibihayat S; Gholizadeh Navashenaq J
Int Immunopharmacol; 2021 Aug; 97():107681. PubMed ID: 33932697
[TBL] [Abstract][Full Text] [Related]
7. Expression of a chemokine BRAK/CXCL14 in oral floor carcinoma cells reduces the settlement rate of the cells and suppresses their proliferation in vivo.
Ito S; Ozawa S; Ikoma T; Yajima N; Kiyono T; Hata R
Biomed Res; 2010 Jun; 31(3):199-206. PubMed ID: 20622470
[TBL] [Abstract][Full Text] [Related]
8. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo.
Shurin GV; Ferris RL; Tourkova IL; Perez L; Lokshin A; Balkir L; Collins B; Chatta GS; Shurin MR
J Immunol; 2005 May; 174(9):5490-8. PubMed ID: 15843547
[TBL] [Abstract][Full Text] [Related]
9. Modulation of CXCL14 (BRAK) expression in prostate cancer.
Schwarze SR; Luo J; Isaacs WB; Jarrard DF
Prostate; 2005 Jun; 64(1):67-74. PubMed ID: 15651028
[TBL] [Abstract][Full Text] [Related]
10. Expression of CXCL14 and its anticancer role in breast cancer.
Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of proximal promoter of gene for human BRAK/CXCL14, a tumor-suppressing chemokine.
Komori R; Ozawa S; Kato Y; Shinji H; Kimoto S; Hata R
Biomed Res; 2010 Apr; 31(2):123-31. PubMed ID: 20460740
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic functions of the CXC-type chemokine CXCL14 in mammals.
Hara T; Tanegashima K
J Biochem; 2012 May; 151(5):469-76. PubMed ID: 22437940
[TBL] [Abstract][Full Text] [Related]
13. BRAK/CXCL14 expression in oral carcinoma cells completely suppresses tumor cell xenografts in SCID mouse.
Ozawa S; Kato Y; Kubota E; Hata R
Biomed Res; 2009 Oct; 30(5):315-8. PubMed ID: 19887729
[TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of CXCL14 in healthy human and murine epithelial tissues.
Meuter S; Moser B
Cytokine; 2008 Nov; 44(2):248-55. PubMed ID: 18809336
[TBL] [Abstract][Full Text] [Related]
15. A New Strategy to Find Targets for Anticancer Therapy: Chemokine CXCL14/BRAK Is a Multifunctional Tumor Suppressor for Head and Neck Squamous Cell Carcinoma.
Hata R
ISRN Otolaryngol; 2012; 2012():797619. PubMed ID: 23762619
[TBL] [Abstract][Full Text] [Related]
16. Upregulated CXCL14 is associated with poor survival outcomes and promotes ovarian cancer cells proliferation.
Li X; Zhao L; Meng T
Cell Biochem Funct; 2020 Jul; 38(5):613-620. PubMed ID: 32077118
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties.
Augsten M; Sjöberg E; Frings O; Vorrink SU; Frijhoff J; Olsson E; Borg Å; Östman A
Cancer Res; 2014 Jun; 74(11):2999-3010. PubMed ID: 24710408
[TBL] [Abstract][Full Text] [Related]
18. Human p38 delta MAP kinase mediates UV irradiation induced up-regulation of the gene expression of chemokine BRAK/CXCL14.
Ozawa S; Ito S; Kato Y; Kubota E; Hata R
Biochem Biophys Res Commun; 2010 Jun; 396(4):1060-4. PubMed ID: 20478268
[TBL] [Abstract][Full Text] [Related]
19. Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer.
Hu C; Lin F; Zhu G; Xue X; Ding Y; Zhao Z; Zhang L; Shen X
Int J Oncol; 2013 Nov; 43(5):1487-94. PubMed ID: 23982764
[TBL] [Abstract][Full Text] [Related]
20. Structural determinants involved in the regulation of CXCL14/BRAK expression by the 26 S proteasome.
Peterson FC; Thorpe JA; Harder AG; Volkman BF; Schwarze SR
J Mol Biol; 2006 Nov; 363(4):813-22. PubMed ID: 16987528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
